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ABSTRACT
Fungal meningitis is an infection which is caused by fungus which spreads through the blood to the spinal cord. People with weakened immunity 
get this disease easily like persons with AIDs, etc. To make sure the disease is fungal meningitis, a sample is taken from the cerebrospinal fluid 
and it is sent to the laboratory. Usually, fungal meningitis is not mediated from person to person, but it is caused when a fungi are inhaled from 
the surrounding and spread into the blood to the central nervous system. Normally medications such as vaccines, IV, and oral suspensions are 
given to the people for curing fungal meningitis. Commonly used drugs are Amphotericin B and fluconazole oral suspension. Amphotericin B is 
an antifungal, antiprotozoal, and hydrophobic drug. However, these drugs cannot give a directly as  medication therapy for the patients, because 
it offers toxic effect and side effects, absorption rate is slower, and crossing the blood–brain barrier (BBB) is getting difficult. Adverse effects can 
be minimized with the application of nanotechnology. Therefore, in human medical services, the availability of molecular nanotechnology will 
provide rapid progress. Nanoparticle (NP) systems help to improve the solubility of poorly water-soluble drugs which has been explained using 
Noyes–Whitney equations. Nanoparticles  offers several advantages as a drug delivery system, such as better drug bioavailability, reduction of 
dosing frequency enables them for the betterment of diseases, can cross the BBB, and it is very cost-effective. Types of NP include polymeric NP, 
carbon nanotubes, metallic structures, nanocrystals, and fusogenic liposomes. Fusogenic liposomes are a peculiar class of phospholipid vesicles. The 
fusogenic liposomes can deliver encapsulated NP into the targeted sites and also can cross the BBB. On comparing with cationic liposomes, fusogenic 
liposomes are more effective as well as rapid in the drug delivery.
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INTRODUCTION
Among different types of fungal infections, one of the types is fungal 
meningitis. Fungal meningitis is caused due to the inhalation of fungus 
spores or localized colonization of the skin. Cryptococcus fungus is 
the main causative organism of fungal meningitis; it is also caused 
by other organisms. The organisms are generally breathed in and 
afterward spread into the blood and to the focal sensory system yet it 
is not spread starting with one individual then onto the next [1]. The 
growths can likewise be specifically embedded into the focal sensory 
system by medicinal methods or can be entered from a tainted site 
close to the focal sensory system which can cause meningitis. Any 
treatment that may debilitate the insusceptible framework may 
prompt high hazard components of contagious meningitis. The other 
hazard factors incorporate surgical methods that are managed with 
no sterility and will acquaint the growths with the focal anxious. 
Cerebral pain, solid neck, queasiness, heaving, photophobia, and 
adjusted mental status are its primary side effects. This is diagnosed 
by blood and culture of cerebrospinal fluid. The most effective thing 
to protect children from meningitis is to provide vaccines that protect 
against most forms of meningitis and septicaemia [2]. Commonly 
IV antifungal drugs and oral suspensions such as fluconazole and 
Amphotericin B drugs are given for this treatment. Different drug 
delivery systems have been developed with the help of nanoparticles 
(NPs) [3].
PATHOGENESIS
The key step for a pathogen to infect the brain and cause 
meningitis is to cross the blood–brain barrier (BBB), an interface 
that separates the peripheral circulation and central nervous 
system [4].
BASIC PATHOLOGY OF FUNGAL MENINGITIS [5]
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TREATMENTS
A lumbar cut that is spinal tap is utilized to analyze meningitis. 
Among this test, a specimen of cerebrospinal liquid is expelled from 
your spine and tried. Antifungal medicines are utilized to treat this 
type of meningitis. Intravenous (IV, through a vein) treatment with 
Amphotericin B is the most widely recognized treatment utilized. It 
is often joined with an oral antifungal medicine called 5-flucytosine. 
Other drugs which are used for this treatment are fluconazole oral, 
Abelcet IV, Diflucan oral, fluconazole in sodium chloride IV, fluconazole 
in dextrose IV, Vfend, Ancobon, IV fluconazole, intrathecal miconazole, 
and so on. On comparing these drugs, we could find that bioavailability 
and more effectiveness are given by amphotericin B. Hence, to achieve 
rapid effectiveness in less time, we can convert this Amphotericin B into 
a nano form. For intracerebral fungal infection OX26-modified AMB-
loaded NP were used. Amphotericin B act by the system, in which it ties 
to the sterol in the layer of sensitive fungi which builds the membrane 
permeability. The toxicity of this compound is due to the non-specificity 
and binding of the mammalian cell cholesterol.
Recently, the first preparation of Amphotericin B (AmBisome) as 
liposome had passed every single clinical trial, and now, it is utilized 
for the treatment of fungal infections as well. Liposomal Amphotericin 
B by latently focusing on the liver and spleen decreases the renal and 
general danger at typical dosage yet renal toxicity shows up when the 
medication is given at raised dose because of the saturation of liver and 
spleen macrophages.
IV Amphotericin B causes important pharmacodynamic interactions 
through additive nephrotoxicity and myelotoxicity and might increase 
the cardio tonicity of other drugs because of amphotericin-induced 
hypokalemia. Lipid formulations of amphotericin Bare less nephrotonic 
than non-lipid formulation. Orally administered Amphotericin B is not 
absorbed systemically. The lipid formulation of Amphotericin B such as 
liposomal Amphotericin B at doses of 4–6 mg/kg/day has comparable 
efficacy than conventional Amphotericin B at a dose of 0.7 mg/kg.
There are two formulations of amphotericin:
1. Standard (conventional)
2. Lipid-based.
Amphotericin- B bind to ergosterol in fungal cell membrane affecting 
its integrity by forming spores and therefore cell death. Nystatin, the 
other polyene is only used topically because of toxicity associated with 
systemic use. On converting the Amphotericin B into a nanoform, we are 
enhancing the effectiveness of the drug that helps to cure this disease.
Fluconazole is another drug used in fungal meningitis. It is resistant for 
Candida glabrata fungi. Its 11% of the dose is excreted through urine 
as metabolite. Fluconazole can be taken with or without food. They 
are available in different dosage forms. Bioavailability of this drug is 
in the form of oral suspension. Sometimes, it can cause several allergic 
reactions, which can be identified by symptoms such as shortness in 
breathing and nausea [6].
Fluconazole is a highly sensitive inhibitor which is having an enzyme 
lanosterol 14-alpha-methylase that depends on fungal cytochrome 
p450. This enzyme is used to convert lanosterol to ergosterol. The 
subsequent loss of normal sterols combines with the accumulation 
of 14-alpha-methyl sterols in fungi and which may be responsible for 
the fungistatic activity of the fluconazole. Using these drugs provides 
a toxicity in our systemic systems as well as provides more time for 
the absorption of the drugs. Hence, we can use these drugs along with 
nanotechnology.
One of the fundamental therapeutic uses of the nano medication is 
that it tries to convey the most important arrangement of research 
apparatuses and clinically valuable gadgets for the not so distant future. 
Utilizing NP nanotechnology has given the possibility of conveying 
medications to the particular cells. Advantage of utilizing nanoscale 
in therapeutic advancements is that Littler devices are less intrusive 
and can be embedded inside the body, and also biochemical response 
times are substantially shorter. The capacity of medication conveyance 
through nano solution depends on:
a.	 Efficient	exemplification	of	the	medication
b. Successful delivery of medication to the focused region of the body
c. Successful arrival of the medication.
NPs can be used in the combination therapy for decreasing antibiotic 
resistance. It is also used to circumvent multidrug-resistance 
mechanism. One of the main advantages of nanomedicine is that 
unsolved medical problems such as cancer are getting benefited by this 
technology.
Disadvantages of nanomedicine are as follows:
1. Lack of knowledge about the effect of NP on biochemical pathways 
and in the processes of the human body.
2. Scientists are mainly concerned about the toxicity, characterization, 
and exposure pathways associated with nanomedicine that 
might pose a serious threat to the human beings as well as to the 
environment.
NANOTECHNOLOGY AND ITS ELEMENTS
NPs
NPs are particles that can be orchestrated synthetically and organically. 
It extends between 1 and 100 nm. They basically happen as strong 
colloidal structures. In nanotechnology, a molecule is characterized 
as a little question that carries on in general unit regarding its vehicle 
and properties [7]. As NPs are sufficiently little to bind their electrons 
and deliver quantum impacts, they regularly have sudden optical 
properties [8]. On contrasting gold pieces and gold NPs, gold NPs 
soften at much lower temperatures (~300°C for 2.5 nm sizes) than the 
gold sections (1064°C). Materials made out of NPs have considerably 
higher assimilation of sun-powered radiation than it is in thin movies of 
persistent sheets of material.
There are diverse techniques for making NP, which incorporate gas 
buildup, steady loss, synthetic precipitation, pyrolysis, and aqueous 
amalgamation. In whittling down technique, full-scale or small-scale 
particles are grounded in a ball process, planetary ball process, or some 
other size-decreasing system. After the procedure, we get a subsequent 
molecule which is air grouped to recuperate NP. In pyrolysis strategy, 
a vaporous forerunner (fluid or gas) is constrained through a hole at 
high weight and consumed. After the procedure, we get a subsequent 
strong (a variant of residue) which is air arranged to recuperate 
oxide particles from the result gasses. On contrasting and customary 
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pyrolysis and single essential particles, conventional pyrolysis regularly 
brings about totals and agglomerates as opposed to single essential 
particles. Ultrasonic spout shower pyrolysis then again helps in keeping 
agglomerates from framing. NP with higher surface area increase the 
poorly water-soluble drugs. NP in liquid suspension produces more 
homogenous product with more shelf life. Delivery strategies include 
injection, oral delivery, delivery to brain, and gene therapy. NPs avoid 
the risk of embolism associated with IV administration. Targeting 
tumors and inflamed vascular regions are possible with their IV 
administration. Oral delivery systems formulated with NP enhanced 
with the bioavailability for poorly water-soluble drugs and systemic 
targeting through circulatory uptake from the intestine. Ocular delivery 
using topical system is challenging due to tear flow, blinking, and 
multiple tissue. NP is found to possess improved accessibility to deep 
ocular tissues; thereby, it maintains improved residence time in eye. 
In drug delivery to the brain, the highly selective BBB can be made of 










Organic frameworks are frequently included with characteristic and 
useful nanomaterials [9]. A few cases of normal natural nanomaterials 
incorporate the structure of foraminifera (mainly chalk) and infections 
(protein and capsid), the wax gems covering a lotus or nasturtium leaf, 
creepy crawly and bug vermin silk, the blue tone of tarantulas, the 
“spatula” on the base of gecko feet, some butterfly wing scales, regular 
colloids, for example, drain, blood, horny materials (skin, paws, noses, 
quills, horns, and hair), hair paper, cotton, nacre, corals, and even our 
own bone grid, and so forth. A characteristic inorganic nanomaterial 
happens through precious stone development in the assorted synthetic 
states of the world’s outside. For instance, dirt showcases complex 
nanostructures because of anisotropy of their hidden precious stone 
structure and volcanic action can offer ascent to opals, which are an 
example of a normally happening photonic gem due to their nanoscale 
structure. Flames speak to, especially, complex responses and can 
deliver colors, concrete, seethed silica, and so on.
Nanomaterials are blended by two fundamental strategies. Right off the 
bat by bottom-up technique besides by top-up strategy. There likewise 
exists engineered strategy for the planning of nanomaterials however 
should display a control over the size which ranges from ~1 to 100 nm 
then no one but it can accomplish its properties.
Bottom-up methods
This strategy includes the gathering of particles or atoms which are 
taken into nanostructured exhibits. Here, the crude material sources 
Nanocapsules
The most well-known routes that to give nanocapsule are nano 
precipitation, emulsion-dissemination, and dissolvable vanishing 
systems. Nano precipitation method is, moreover, called removal 
strategy. Inside the nanoprecipitation procedure, nano cases are formed 
by influencing a colloidal arrangement between the 2 and isolate stages. 
The natural part comprises of an answer and a blend of natural solvents 
though the parallel compound part comprises of a blend of non-solvents 
that structure a surface film. The natural part is gradually infused inside 
the paired compound part that is then unsettled to make the colloidal 
arrangement. Once the colloidal arrangement is influenced, it will to be 
Controlled processes
This  procedure  includes  lifting  the  particles  or  atoms  to  a 
tumultuous  state  and  after  that  all  of  a  sudden  changing  the 
conditions  in  order  to  make  that  state  unsteady.  Cases  of  chaotic 
processes are laser removal, exploding wire, arc, flame pyrolysis, 
combustion, and precipitation blend procedures.
can  be  in  type  of  gasses,  fluids,  or  solids.  Base  techniques  by  and 
large  partitioned  into  two  classes:  Tumultuous  and  controlled 
procedures.
Chaotic processes
This  procedure  includes  lifting  the  particles  or  atoms  to  a 
tumultuous  state  and  after  that  all  of  a  sudden  changing  the 
conditions  in  order  to  make  that  state  unsteady.  Cases  of  chaotic 
processes are laser removal, exploding wire, arc, flame pyrolysis, 
combustion, and precipitation blend procedures.
It is mainly made up of non-toxic polymer and is made up of nanoscale 
shells. They are sac systems manufactured from a chemical compound 
membrane  that  encapsulates  an  inner  liquid  core  at  the 
nanoscale.  Nanocapsules  have  several  uses  as  well  as  medical 
applications  for  drug  delivery,  food  sweetening,  nutraceuticals,  and 
additionally for self-healing materials. The advantages of encapsulation 
strategies square measure the protection of those substances within the
 adverse  surroundings,  for  controlled  unleash,  and  for  preciseness 
targeting  [10,11]  Nanocapsules  will  doubtless  be  used  as  associate 
magnetic  resonance  imaging-guided  nanorobots  or  nanobots.  The 
traditional  size  of  a  nanocapsule  used  for  varied  applications 
ranges from 10 to 1000 nm. However, counting on the preparation 
and use of the nanocapsule, the dimensions are going to be a lot 
of specific. The structure of a nanocapsule consists of nanosac system 
that  is  shaped  in  a  very  core-shell  arrangement.  The  shell  of  a 
nanocapsule is framed of a compound layer or a covering. The 
sort of polymers utilized is of perishable polyester because of 
nanocapsule  square  measure  normally  used  in  organic 
frameworks.  Chiefly  polymers  are  used  Nanocontainer  development 
square  measure  Poly-e-caprolactone,  poly  (lactide),  and  poly 
(lactide-co-glycoside).  Distinctive  polymers  grasp  nacked  poly 
(methacrylic corrosive) and poly (N-vinylpyrrolidone). Comparing 
with manufactured polymers and present polymers, counterfeit 
polymers  have  checked  to  be  a  considerable  measure  of 
unadulterated and steady. They are normally most prevalent for the
 advancement of nanocapsules. Some present polymers such as 
chitosan, gelatin, sodium alginate, and egg whites square measure
 used  in  some  medication  conveying  nanocapsules.  Diverse 
nanocontainer shells grasp liposomes with polysaccharides and 
saccharides.  Polysaccharides  and  saccharides  square  measure 
utilized because of their non-harmfulness and biodegradability. The 
center of a nanocapsule comprises of an oil substance specialist that is 
particularly organized the picked tranquilize inside the compound film. 
The specific oil that is utilized ought to be amazingly dissolvable with 
the medication, and non-lethal once used in a natural environment. 
The oil-medicate emulsion ought to have low dissolvability with the 
compound layer to affirm that the medication is conveyed all through
 the framework appropriately and be released at the right time and site. 
Once the right emulsion is gotten, the medication should be consistently 
spread  all  through  the  entire  inner  depression  of  the  compound 
film. These procedures depend on the physiochemical properties
 of  the  center  material,  the  divider  material,  and  furthermore  the 
required size.
98
Asian J Pharm Clin Res, Vol 11, Issue 12, 2018, 95-101
 Alex et al. 
upset until the nanocontainers started to make. The scale and type of 
the nanocontainer rely on the speed of the infusion in conjunction with 
the speed of disturbance.
Another common way to prepare nanocapsules is the emulsion 




Another effective methodology used for the preparation of nanocapsule 
is solvent evaporation methodology. During this methodology, single 
or double emulsions square measure fashioned from solvents and 
square measure would not to formulate a NP suspension. High-speed 
blend or ultrasonication is employed to create tiny particle size within 
the NP suspension. Once the suspension is stable, the solvents square 
measure gaseous mistreatment either continuous magnetic stirring at 
temperature or by reducing the close pressure.
Nanotubes
It is a tube-like structure of a nanometer scale which is also known as 
NP. They are large enough channels compared to other NP. The first 
discovered nanotubes are carbon nanotubes.
Carbon nanotubes
Carbon nanotubes are carbons that are capable of forming many 
allotropes due to its valency with a cylindrical nanostructure [13]. 
Nanotubes have extraordinary thermal conductivity mechanism. 
Carbon nanotubes are carbons that are fit for framing numerous 
allotropes because of its valency with a round and hollow nanostructure. 
Nanotubes have exceptional warm conductivity instrument and 
electrical properties. They discover applications in different auxiliary 
materials such as polished ash, golf clubs, auto parts. or Damascus steel. 
According to quantum chemistry, the chemical bonding in nanotubes is 
described through orbital hybridization.
There are different types of carbon nanotubes, they are as follows:
•	 Single-walled	carbon	nanotubes:	Its	diameter	is	about	1	nm.	It	is	one	
of the important varieties of carbon nanotubes.
•	 Multiple-walled	carbon	nanotubes:	 It	 consists	of	multiple	moved	
layers of graphene. These can be described by two models: Russian 
Doll model and material model.
•	 Double-walled	carbon	nanotubes:	It	forms	a	special	class	of	nanotube.	
They	find	applications	in	various	structural	materials	such	as	baseball	
bats, golf clubs, car parts, or Damascus steel.






Nanocrystals are NP containing <100 nm. It is made up of atoms 
either which is in a single or polycrystalline arrangement. They are 
layered, and it is applied to flexible substrates to produce solar panels. 
Nanocrystals, which can be done by converting it into nanosized 
particles. It can then be suspended into liquids, pressed into tablets, 
and made into powder.
They are used in the manufacture of filters that refine crude oil into 
diesel fuel. Possible future uses are production of hydrogen, removal of 
pollutants and toxins, medical imaging, drug manufacture, and protein 
analysis.
Nanocrystals can be synthesized by traditional method. It involves 
molecular precursor that is typical metal salts and a source of 
the anion. Semiconducting nanomaterials have features such as 
chalcogenide and pnictides. These elements are from silylated 
derivatives such as bis (trimethylsilyl) sulfide (S (SiMe3)2 and Tris 
(trimethylsilylphosphine(p(SiMe3)3). Surfactants are used to solubilize 
the growing nanocrystals in some procedures. Nanocrystals may 
exchange their elements with reagents through atomic diffusion.
Nanogels
A nanogel is a NP which is composed of hydrogel. They are composed of 
polymers which are chemically or physically cross-linked [14-16].
Liposome
A liposome is a round vesicle which is having number <1 lipid bilayer. 
By upsetting organic films (for example, by sonification), liposomes can 
be readied. Liposomes are for the most part made out of phospholipids, 
particularly phosphatidylcholine; however, it might likewise incorporate 
different lipids, for example, egg phosphatidylethanolamine, so 
they can be sufficiently long as they are good with the lipid bilayer 
structure [17,18]. A liposome comprises of surface ligands for 
appending to the unfortunate tissue. Liposome can likewise be focused 
to lungs by covering vesicle with o-stearoyl amylopectin, poly oxyl-
ethylene, or mono-sialogangliocyte [19]. The epitome of hostile to 
In this methodology,  the organic section is  additional  to the 
binary  compound  section  below  conditions  of  high  agitation  that 
kind of an emulsion.  Throughout this method, water is additional to 
the emulsion that causes the solvent to diffuse [12]. The results 
of this emulsion diffusion methodology are nanocapsule formation.
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A less alluring structure is multivesicular liposomes in which one 
vesicle contains at least one little vesicles [21].
Liposomes can interact with cells by five different mechanisms [24].
Fusogenic liposomes
Fusogenic liposomes are a peculiar class of phospholipid vesicles [25]. 
At several environmental conditions, the liposomes having lipids that 
promote the [26] destabilisation of fungal membrane are called fusogenic 
liposome or pH-sensitive liposomes [27]. Afusogenic liposome is utilized 
for conveying a liposome captured compound into the cytoplasm of a 
focused on cell [28]. The liposomes have an external surface which is 
of a covering with artificially releasable hydrophilic polymer chains 
that shield hydrophobic polymers on the liposome external surface. 
Arrival of the hydrophilic polymer chains uncovered the hydrophobic 
polymers for the collaboration with external cell films of the objective 
cells to advance the combination of the liposome with the focused on 
cells [29,30]. This is one of the techniques utilized for the organization 
to convey a compound to the objective cells and is likewise a strategy 
for choosing appropriate hydrophobic polymers for the utilization in the 
arrangement. Fusogenic liposomes can convey embodied NP into the 
focused on locales and furthermore can cross the BBB [31-35].
CONCLUSION
Hereby, we can conclude that fungal meningitis is a fungal infection 
which is caused by a fungus spreading through the blood into the spinal 
cord and to the brain. People with weak immunity have this disease. 
Drugs on coating with nanopolymers are used to deliver the drugs. 
They can be easily crossed through the BBB. On converting the drugs 
into a nano form, it makes easy for the absorption as well as for the fast 
recovery. Liposomes are used as the nanocarriers for the drug delivery. 
They are composed of phospholipids, which have the capacity to form 
structures with barrier properties. They became popular with their 
efficiency, biocompatibility, and non-immunogenicity and also enhanced 
the solubility of chemotherapeutic agents. Fusogenic liposomes can 
deliver encapsulated NP into the targeted sites and also can cross the 
BBB. One of the rare characteristics for fusogenic liposomes is that they 
can intertwine with an assortment of mammalian cell membranes and 
convey their substance, which are exemplified in liposomes, into the 
cytoplasm. Fusogenic liposomes can convey different macromolecules, 
for example, plasmids, oligonucleotides, or NP, and in addition, they 
are cytosolic conveys delivers. On comparing with cationic liposomes, 
fusogenic liposomes are more effective as well as rapid in drug delivery.
AUTHORS’ CONTRIBUTIONS
These authors contributed equally to this work.
CONFLICTS OF INTEREST
The authors have declared no conflicts of interest.
1. Honda H, Warren DK. Central nervous system infections: Meningitis 
and brain abscess. Infect Dis Clin North Am 2009;23:609-23.
2. Venkatakrishnan K, von Moltke LL, Greenblatt DJ. Effects of the 
antifungal agents on oxidative drug metabolism: Clinical relevance. 
Clin Pharmacokinet 2000;38:111-80.
3. Mohammed N, Rejinold NS, Mangalathillam S, Biswas R, Nair SV, 
Jayakumar R, et al. Fluconazole loaded chitin nanogels as a topical 
tubercular operator such as isoniazid and rifampicin in lung focused on 
liposome  adjusts  the  lethality  and  enhances  the  productivity  of 
these medications [20]. They have good entrapment efficiency than
 others. These are the most extensively developed nanocarrier for 
novel and the targeted therapy. They have both determination and
 additionally  remedial  property.  They  have  low  poisonous  quality. 
They  are  usually  made  out  of  at  least  one  amphiphilic  phospholipid 




Liposomes  with  a  little  distance  across  (50–100  nm)  and 
additionally  extensive  breadth  experience  free  dissemination 
through  the  blood– brain  barrier  (BBB).  It  is  conceivable  that  a 
SUVs which are coupled to cerebrum medicate transport vectors 
can  be  transported  through  the  BBB  by  receptor  interceded  or 
absorptive  intervened  transcytosis.  Likewise,  to  experience 
absorptive  intervened  endocytosis  into  the  cells,  cationic 
liposomes  were  created  as  of  late  which  demonstrated  these 
structures. The vehicle of substances through BBB by liposomes was 
broadly examined.  The imperative discovering issues from their 
examinations are that the expansion of the sulfatide (a sulfur ester 
of  galactocerebroside)  to  liposome  synthesis  expands  their 
capacity  to  cross  the  BBB  [21].  Wangetal  finished  up  with  his  report 
that  liposomes  covered  with  the  mannose  achieve  the 
cerebrum  tissue  and  the  mannose  coat  help  the  vehicle  of  the 
stacked medication through BBB.  By giving fundamentally  course 
of  organization,  the  neuropeptides,  leuenkephalin,  and 
mefenkephalinkyoforphin regularly do not cross the BBB [22]. 
The  energizer  amitriptyline  typically  infiltrates  the  BBB, 
because of adaptability of this strategy. NPs were manufactured by 
utilizing  different  stabilizers.  At  the  point  when  the  substance  was 
adsorbed onto the NP and covered or molecule settled with polysorbate 
85, it was discovered that amitriptyline level has altogether improved
 in the cerebrum [23].
100
Asian J Pharm Clin Res, Vol 11, Issue 12, 2018, 95-101
 Alex et al. 
ocular drug delivery agent for corneal fungal infections. J Biomed 
Nanotechnol 2013;9:1521-31.
4. Walker R, Whittlesea C. Clinical Pharmacy and Therapeutics. 5th ed. 
London: Churchill Livingstone; 2011. p. 661.
5. Mendez-Vilas A. Science against microbial pathogens: Communicating 
current research and technological advances. Current 2011;2:1-691.
6. Porter RS, Kalpan JL. The Merck Manual of Diagnosis and Therapy. 
19th ed. London: Merck and Co., Inc; 1930. p. 1321-2.
7. Nagavarma BV, Hemant KS, Ayaz A, Vasudha LS, Shivakumar HG. 
Different techniques for preparation of polymeric nanoparticles- a 
review. Asian J Pharm Clin Res 2012;5:16-23.
8. Chien S. Intracellular ATP delivery using highly fusogenic liposomes. 
In: Weissig V, editor. Liposomes: Methods and Protocols. Vol.1: 
Pharmaceutical Nanocarriers. New York: Springer; 2009. p. 377-91.
9. Ezhilarasi PN, Karthik P, hhanwal N, Anandharamakrishnan C. 
Nanoencapsulation techniques for food bioactive components: 
A review. Food Bioproc Technol 2012;6:628-47.
10. Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules 
for drug delivery. Int J Pharm 2010;385:113-42.
11. Olga S, Yan Y, Yajun W, Frank C. Shape-dependent cellular processing 
of polyelectrolyte capsules. ACS Nano 2013;7:522-30.
12. Ren WH, Chang J, Yan CH, Qian XM, Long LX, He B, et al. 
Development of transferrin functionalized poly(ethylene glycol)/
poly(lactic acid) amphiphilic block copolymeric micelles as a potential 
delivery system targeting brain glioma. J Mater Sci Mater Med 
2010;21:2673-81.
13. Takeuchi K, Hayashi T, Kim YA, Fujisawa K, Endo M. The state-of-
the-art science and applications of carbon nanotubes. Nano J Ifmo Ru 
2014;5:15.
14. Mangalathillam S, Rejinold NS, Nair A, Lakshmanan VK, Nair SV, 
Jayakumar R, et al. Curcumin loaded chitin nanogels for skin cancer 
treatment via the transdermal route. Nanoscale 2012;4:239-50.
15. Singh SS, Roy A, Lee B, Banerjee I, Kumta PN. Synthesis, 
characterization, and in-vitro cytocompatibility of amorphous β-tri-
calcium magnesium phosphate ceramics. Mater Sci Eng C Mater Biol 
Appl 2016;67:636-45.
16. Kabanov AV, Vinogradov SV. Nanogels as pharmaceutical carriers: 
Finite networks of infinite capabilities. Angew Chem Int Ed Engl 
2009;48:5418-29.
17. Nakanishi M, Mizuguchi H, Ashihara K, Senda T, Eguchi A, Watabe A, 
et al. Gene delivery systems using the Sendai virus. Mol Membr Biol 
1999;16:123-7.
18. Yoshikawa T, Imazu S, Gao JQ, Hayashi K, Tsuda Y, Okada N, et al. 
Non-methylated cpG motif packaged into fusogenic liposomes enhance 
antigen-specific immunity in mice. Biol Pharm Bull 2006;29:105-9.
19. Deshpande PP, Biswas S, Torchilin VP. Current trends in the use of 
liposomes for tumor targeting. Nanomedicine (Lond) 2013;8:1509-28.
20. Wiener N, Lieb L. Medical Applications of Liposome. Oxford: Elsevier; 
1998.
21. Kunisawa J, Masuda T, Katayama K, Yoshikawa T, Tsutsumi Y, 
Akashi M, et al. Fusogenic liposome delivers encapsulated nanoparticles 
for cytosolic controlled gene release. J Control Release 2005;105:344-53.
22. Freise J, Magerstedt P. Liposomes as a Drug Carrier. Stuttgart: George 
ThiemeVerlag; 1986.
23. Ranade VV. Drug delivery systems 1. Site-specific drug delivery using 
liposomes as carriers. J Clin Pharmacol 1989;29:685-94.
24. Boomer JA, Qualls MM, Inerowicz HD, Haynes RH, Patri VS, 
Kim JM, et al. Cytoplasmic delivery of liposomal contents mediated by 
an acid-labile cholesterol-vinyl ether-PEG conjugate. Bioconjug Chem 
2009;20:47-59.
25. Meers PR, Shangguan T, Cabral-Lilly D, Ahl P, Erukulla R, Janoff A. 
Modular Targeted Liposomal Delivery Systems. US: US Patent; 2006.
26. Kunisawa J, Nakagawa S, Mayumi T. Pharmacotherapy by intracellular 
delivery of drugs using fusogenic liposomes: Application to vaccine 
development. Adv Drug Deliv Rev 2001;52:177-86.
27. Yoshikaw T. Fusogenic liposomes and their suitability for gene delivery. 
Future Lipidol 2006;1:735-42.
28. Karanth H, Murthy RS. PH-sensitive liposomes – principle and 
application in cancer therapy. J Pharm Pharmacol 2007;59:469-83.
29. Shangguan T, Cabral-Lilly D, Purandare U, Godin N, Ahl P, Janoff A, et al. 
A novel N-acyl phosphatidylethanolamine-containing delivery vehicle for 
spermine-condensed plasmid DNA. Gene Ther 2000;7:769-83.
30. Cullis PR, Choi LS, Monck M, Bailey AL. Fusogenic Liposomes. US: 
US Patent; 2003.
31. Simões S, Moreira JN, Fonseca C, Düzgüneş N, de Lima MC. On the 
formulation of pH-sensitive liposomes with long circulation times. Adv 
Drug Deliv Rev 2004;56:947-65.
32. Li H, Nelson CE, Evans BC, Duvall CL. Delivery of intracellular-acting 
biologics in pro-apoptotic therapies. Curr Pharm Des 2011;17:293-319.
33. Csiszár A, Hersch N, Dieluweit S, Biehl R, Merkel R, Hoffmann B, 
et al. Novel fusogenic liposomes for fluorescent cell labeling and 
membrane modification. Bioconjug Chem 2010;21:537-43.
34. Mustata RC, Grigorescu A, Petrescu SM. Encapsulated cargo 
internalized by fusogenic liposomes partially overlaps the endoplasmic 
reticulum. J Cell Mol Med 2009;13:3110-21.
35. Jilsha G, Viswanad V. Nanosponges: A novel approach of drug delivery 
system. Int J Pharm Sci Rev Res 2013;19:119-23.
36. Karenbaxter A, Preston CL. Stockley’s Drug interaction. 10th ed. 
New York: Marcel Dekker; 2012. p. 210.
37. Grubber SM. Liposome Biophysics Therapeutics. New York: Marcel 
Dekker; 1987.
38. Shim MS, Kwon YJ. Efficient and targeted delivery of siRNA in vivo. 
FEBS J 2010;277:4814-27.
39. Vartholomeos P, Fruchard M, Ferreira A, Mavroidis C. MRI-guided 
nanorobotic systems for therapeutic and diagnostic applications. Annu 
Rev Biomed Eng 2011;13:157-84.
40. Michel V, Yoshiharu D, Karl-Heinz H, Michael H, Philip H, 
Przemyslaw K, et al. Terminology for bio related polymers and 
applications (IUPAC recommendations 2012. Pure Appl Chem 
2012;84:377–410.
41. Brian PT, Kathryn W, Weiwei G, Daniel SK, Omid F, Daniel A, et al. 
Advances in drug delivery. Ann Rev Matr Res 2011;41:1-20.
42. Fuhr O, Dehnen S, Fenske D. Chalcogenide clusters of copper and silver 
from silyliatedchalcogenide sources. Chem Soc Rev 2013;42:1871-906.
43. Department of Biopharmaceutics, Graduate School of Pharmaceutical 
Sciences. Suita, Osaka: Osaka University 1-6 Yamadaoka. p. 565-871.
44. Mok KW, Cullis PR. Structural and fusogenic properties of cationic 
liposomes in the presence of plasmid DNA. Biophys J 1997;73:2534-45.
45. Bencherif SA, Siegwart DJ, Srinivasan A, Horkay F, Hollinger JO, 
Washburn NR, et al. Nanostructured hybrid hydrogels prepared by a 
combination of atom transfer radical polymerization and free radical 
polymerization. Biomaterials 2009;30:5270-8.
46. Cui J, Ren B, Tong Y, Dai H, Zhang L. Synergistic combinations of 
antifungals and anti-virulence agents to fight against Candida albicans. 
Virulence 2015;6:362-71.
47. Priyanka R, Bhattacharya S. A review on promising antibiotic therapy 
by novel delivery system. Asian J Pharm Clin Res 2018;11:5.
48. Chandran PK, Ulagan MP. Antimicrobial and anticancer activity of silver 
nanoparticles from edible mushroom. Asian J Pharm Clin Res 2017;10:3.
49. Kadian R. Nanoparticles: A promising drug delivery approach. Asian J 
Pharm Clin Res 2018;11:1.
50. Davis S. Drug delivery systems interdisciplinary. Sci Rev 2000;25:175.
51. Couvreur P, Barratt G, Fattal E, Legrand P, Vauthier C. Nanocapsule 
technology: A review. Crit Rev Ther Drug Carrier Syst 2002;19:99-134.
52. Ringe K, Walz C, Sabel B. Nanoparticle drug delivery to the brain. In: 
Nalwa, HS, editor. Encylopedia of Nano Science and Nanotechnology. 
New York: American Scientific Publishers; 2004.
53. Tiwari KB, Rijal B, Ghimire P, Sharma AP. Acute bacterial meningitis 
in nepal. Nepal Med Coll J 2007;9:100-3.
54. Esta LP, Castanedapastor A, Navarrom G, Gcercia-Madero R, 
Lopez-Cano Gomez M, Ayud-fernandez M. Comparative studies of 
Staphylococcus aures and Coagulase negative staphylococci in adults. 
Rev Neurol 2009;48:2-6.
55. Perelshtein I, Applerot G, Perkas N, Guibert G, Mikhailov S, 
Gedanken  A, et al. Sonochemical coating of silver nanoparticles on 
textile fabrics (nylon, polyester and cotton) and their antibacterial 
activity. Nanotechnology 2008;19:245705.
56. Bender AR, von Briesen H, Kreuter J, Duncan IB, Rübsamen-
Waigmann H. Efficiency of nanoparticles as a carrier system for antiviral 
agents in human immunodeficiency virus-infected human monocytes/
macrophages in vitro. Antimicrob Agents Chemother 1996;40:1467-71.
57. Jahanshahi M, Babali Z. Protein nanoparticle: A unique system as drug 
delivery vehicles. Afr J Biotech 2008;7:4926.
58. Schroeder U, Sommerfeld P, Ulrich S, Sabel BA. Nanoparticle 
technology for delivery of drugs across the blood-brain barrier. J Pharm 
Sci 1998;87:1305-7.
59. Christophe LJ, Allémann F, Jaeghere FD, Doelker E, Gurny R. 
Biodegradable nanoparticles-from sustained release formulations to 
improved site specific drug delivery. J Control Release 1996;39:339.
60. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the 
clearance and biodistribution of polymeric nanoparticles. Mol Pharm 
2008;5:505-15.
61. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. 
Biodegradable polymeric nanoparticles as drug delivery devices. 
101
Asian J Pharm Clin Res, Vol 11, Issue 12, 2018, 95-101
 Alex et al. 
J Control Release 2001;70:1-20.
62. Mahapatro A, Singh DK. Biodegradable nanoparticles are excellent 
vehicle for site directed in-vivo delivery of drugs and vaccines. 
J Nanobiotechnology 2011;9:55.
63. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and 
gene delivery to cells and tissue. Adv Drug Deliv Rev 2003;55:329-47.
64. Forier K, Raemdonck K, De Smedt SC, Demeester J, Coenye T, 
Braeckmans K, et al. Lipid and polymer nanoparticles for drug delivery 
to bacterial biofilms. J Control Release 2014;190:607-23.
65. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, 
Scheld WM, et al. Practice guidelines for the management of bacterial 
meningitis. Clin Infect Dis 2004;39:1267-84.
66. Kanra G, Akan O, Ecevit Z, Ceyhan M, Seçmeer G. Microorganisms 
involved in acute bacterial meningitis in children and the role of 
haemophilus influenzae. Turk J Pediatr 1996;38:407-12.
67. Gray LD, Fedorko DP. Laboratory diagnosis of bacterial meningitis. 
Clin Microbiol Rev 1992;5:130-45.
68. Csiszár A, Csiszar A, Pinto JT, Gautam T, Kleusch C, Hoffmann 
B, et al. Resveratrol encapsulated in novel fusogenic liposomes 
activates nrf2 and attenuates oxidative stress in cerebromicrovascular 
endothelial cells from aged rats. J Gerontol A Biol Sci Med Sci 
2015;70:303-13.
69. Mriouah J, Nesbitt RN, Pink D. Fusogenic liposome: A novel 
therapeutic strategy to efficiently target and destroy prostate cancer. 
Cancer 2014;2014:821.
70. Yoshikawa T, Imazu S, Gao JQ, Hayashi K, Tsuda Y, Okada N, et al. 
Non-methylated cpG motif packaged into fusogenic liposomes enhance 
antigen-specific immunity in mice. Biol Pharm Bull 2006;29:105-9.
71. Bartomeu Garcia C, Shi D, Webster TJ. Tat-functionalized liposomes 
for the treatment of meningitis: An in vitro study. Int J Nanomedicine 
2017;12:3009-21.
72. Csiszár A, Hersch N, Dieluweit S, Biehl R, Merkel R, Hoffmann B, 
et al. Novel fusogenic liposomes for fluorescent cell labeling and 
membrane modification. Bioconjug Chem 2010;21:537-43.
73. Kleusch C, Hersch N, Hoffmann B, Merkel R, Csiszár A. Fluorescent 
lipids: Functional parts of fusogenic liposomes and tools for cell 
membrane labeling and visualization. Molecules 2012;17:1055-73.
74. Kube S, Hersch N, Naumovska E, Gensch T, Hendriks J, Franzen A, 
et al. Fusogenic liposomes as nanocarriers for the delivery of 
intracellular proteins. Langmuir 2017;33:1051-9.
75. Leenders AC, Daenen S, Jansen RL, Hop WC, Lowenberg B, 
Wijermans PW, et al. Liposomal amphotericin B compared with 
amphotericin B deoxycholate in the treatment of documented and 
suspected neutropenia-associated invasive fungal infections. Br J 
Haematol 1998;103:205-12.
76. Mills W, Chopra R, Linch DC, Goldstone AH. Liposomal amphotericin 
B in the treatment of fungal infections in neutropenic patients: A single-
centre experience of 133 episodes in 116 patients. Br J Haematol 
1994;86:754-60.
77. Ng TT, Denning DW. Liposomal amphotericin B (AmBisome) 
therapy in invasive fungal infections. Evaluation of United Kingdom 
compassionate use data. Arch Intern Med 1995;155:1093-8.
78. Boswell GW, Buell D, Bekersky I. AmBisome (liposomal amphotericin 
B): A comparative review. J Clin Pharmacol 1998;38:583-92.
79. Scarcella A, Pasquariello MB, Giugliano B, Vendemmia M, de Lucia A. 
Liposomal amphotericin B treatment for neonatal fungal infections. 
Pediatr Infect Dis J 1998;17:146-8.
80. Lopez-Berestein G, Bodey GP, Fainstein V, Keating M, Frankel LS, 
Zeluff B, et al. Treatment of systemic fungal infections with liposomal 
amphotericin B. Arch Intern Med 1989;149:2533-6.
81. Johnson EM, Ojwang JO, Szekely A, Wallace TL, Warnock DW. 
Comparison of in vitro antifungal activities of free and liposome-
encapsulated nystatin with those of four amphotericin B formulations. 
Antimicrob Agents Chemother 1998;42:1412-6.
82. Brajtburg J, Powderly WG, Kobayashi GS, Medoff G. Amphotericin 
B: Current understanding of mechanisms of action. Antimicrob Agents 
Chemother 1990;34:183-8.
83. Brajtburg J, Powderly WG, Kobayashi GS, Medoff G. Amphotericin B: 
Delivery systems. Antimicrob Agents Chemother 1990;34:381-4.
84. Weber RS, Lopez-Berestein G. Treatment of invasive aspergillus sinusitis 
with liposomal-amphotericin B. Laryngoscope 1987;97:937-41.
85. Bellocchio S, Gaziano R, Bozza S, Rossi G, Montagnoli C, Perruccio K, 
et al. Liposomal amphotericin B activates antifungal resistance with 
reduced toxicity by diverting toll-like receptor signalling from TLR-2 
to TLR-4. J Antimicrob Chemother 2005;55:214-22.
86. Chang HI, Yeh MK. Clinical development of liposome-based 
drugs: Formulation, characterization, and therapeutic efficacy. Int J 
Nanomedicine 2012;7:49-60.
87. Allen TM, Cullis PR. Liposomal drug delivery systems: From concept 
to clinical applications. Adv Drug Deliv Rev 2013;65:36-48.
